Send in the Pentarins: Tarveda raises $30M Series D
Like deadly paratroopers descending from the skies, Tarveda's Pentarin drug conjugates are designed to infiltrate dense tumors, triggering a controlled cell death as they are internalized or bound. It's an ADC variation that's gaining momentum and cash.